Results 1 to 10 of about 5,393 (50)

Safety and immunogenicity of inactivated COVID-19 vaccination in adult rheumatic patients in South China: a prospective study

open access: yesHuman Vaccines & Immunotherapeutics, 2022
Patients with rheumatic diseases (RD) are considered to be a high-risk population for infection with the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2).
Huiqiong Zeng   +11 more
doaj   +1 more source

LncRNA H19 induces immune dysregulation of BMMSCs, at least partly, by inhibiting IL-2 production

open access: yesMolecular Medicine, 2021
Background Systemic lupus erythematosus (SLE) is a representative systemic autoimmune disease. LncRNA H19 has been identified to participate in various biological processes in human diseases. However, the role of H19 in SLE remains unclear.
Xinpeng Chen   +7 more
doaj   +1 more source

Increased risk of herpes zoster with tofacitinib treatment in Korean patients with rheumatoid arthritis: a single-center prospective study

open access: yesScientific Reports, 2023
We aimed to determine the risk of herpes zoster (HZ) in Korean rheumatoid arthritis (RA) patients on tofacitinib compared with tumor necrosis factor inhibitor (TNFi) treatment.
Yeo-Jin Song   +12 more
doaj   +1 more source

Elderly onset atypical Lemierre’s syndrome concurrent with a rheumatoid vasculitis sacral ulcer infection: a case report

open access: yesBMC Infectious Diseases, 2023
Background Typical Lemierre’s syndrome is usually secondary to an oropharyngeal infection. Recently, several cases following a primary infection site other than the oropharynx have been reported as atypical Lemierre’s syndrome; although, these primary ...
Koji Mishima   +9 more
doaj   +1 more source

Enabling personal recovery from fibromyalgia – theoretical rationale, content and meaning of a person-centred, recovery-oriented programme

open access: yesBMC Health Services Research, 2021
Background Fibromyalgia (FM) is a contested, chronic widespread pain syndrome on which recommended therapies have short-lasting, moderate effects. Nevertheless, some patients become symptom-free, and their recovery experiences inspired us to develop a ...
Anne Marit Mengshoel   +8 more
doaj   +1 more source

IgG anti-hinge antibodies against IgG4 F(ab’)2 fragments generated using pepsin are useful diagnostic markers for rheumatoid arthritis: implications of the possible roles of metalloproteinases and IgG subclasses in generating immunogenic hinge epitopes

open access: yesArthritis Research & Therapy, 2020
Background Pepsin agglutinators, discovered over 50 years ago, have been recently referred to as anti-hinge antibodies (AHAs) because of their reaction with the IgG hinge epitope.
Toshiyuki Ota   +3 more
doaj   +1 more source

Evaluation of adherence to calcium, vitamin D and drugs for osteoporosis in patients with low bone mineral density [PDF]

open access: yesSrpski Arhiv za Celokupno Lekarstvo, 2017
Introduction/Objective. Osteoporosis is a systemic disease of bone tissue, which leads to an increase in bone fragility and higher risk of fractures. The aim of the study was to determine adherence to calcium, vitamin D, and drugs for osteoporosis in ...
Maksimović Marina   +5 more
doaj   +1 more source

Lifestyle factors predict gout outcomes: Results from the NOR-Gout longitudinal 2-year treat-to-target study

open access: yesRMD Open, 2023
Objective Gout is associated with lifestyle, body mass index (BMI) and comorbidities, including dyslipidaemia. We studied how in actively treated patients, anthropometric measures and lipid levels changed over 2 years and whether they predicted gout ...
Tore K Kvien   +5 more
doaj   +1 more source

Low BASDAI score alone is not a good predictor of anti-tumor necrosis factor treatment efficacy in ankylosing spondylitis: a retrospective cohort study

open access: yesBMC Musculoskeletal Disorders, 2021
Background The purpose of this study was to determine the prevalence of high disease activity as measured using the Ankylosing Spondylitis Disease Activity Score (ASDAS) in ankylosing spondylitis (AS) patients who nonetheless have low Bath Ankylosing ...
Bora Nam   +7 more
doaj   +1 more source

A systematic review of CXCL13 as a biomarker of disease and treatment response in rheumatoid arthritis

open access: yesBMC Rheumatology, 2020
Background The B cell chemoattractant CXCL13 is a promising biomarker in rheumatoid arthritis (RA), with a plausible role in supporting diagnosis, monitoring disease activity and as a prognostic value.
Katie Bechman   +4 more
doaj   +1 more source

Home - About - Disclaimer - Privacy